Figure S11. Additive effects (“A”) on splicing efficiency of cis-regulatory variants under treatment (“A_PladB”) and control (“A_DMSO”) samples.

We used the lower percent spliced in (PSI) value of the two alleles as starting PSI and the higher one as the final PSI to calculate the effects on splicing efficiency of cis-regulatory variants under treatment and control samples separately and compared “A” between the two conditions. Wilcoxon rank-sum test was used to test the difference.